Trial Outcomes & Findings for Fundus Findings and Thiol-Disulfide Homeostais (NCT NCT05958927)

NCT ID: NCT05958927

Last Updated: 2025-03-10

Results Overview

All patients underwent a 50-g GTT at any time of the day. Women with ≥ 140 mg/dL on the 50-g GTT in the first hour but with a normal 100-g oral GTT level were included in the hyperglycemia group. Women with a 50-g GTT level \< 140 mg/dL were categorized as normal and included in the control group

Recruitment status

COMPLETED

Target enrollment

60 participants

Primary outcome timeframe

26 weeks of pregnant

Results posted on

2025-03-10

Participant Flow

medical clinic

women with impaired glucose status and normal glucose status

Participant milestones

Participant milestones
Measure
Control Group
Non diabetic women tear test and eye measurement: tear test and eye measurement
Case Group
Women with impairment glucose status tear test and eye measurement: tear test and eye measurement
Overall Study
STARTED
34
26
Overall Study
COMPLETED
34
26
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Fundus Findings and Thiol-Disulfide Homeostais

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=34 Participants
Non diabetic women tear test and eye measurement: tear test and eye measurement
Case Group
n=26 Participants
Women with impairment glucose status tear test and eye measurement: tear test and eye measurement
Total
n=60 Participants
Total of all reporting groups
Age, Continuous
25.94 years
STANDARD_DEVIATION 4.50 • n=5 Participants
28.30 years
STANDARD_DEVIATION 4.81 • n=7 Participants
27.05 years
STANDARD_DEVIATION 4.86 • n=5 Participants
Sex: Female, Male
Female
34 Participants
n=5 Participants
26 Participants
n=7 Participants
60 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
34 Participants
n=5 Participants
26 Participants
n=7 Participants
60 Participants
n=5 Participants
Region of Enrollment
Turkey
34 Participants
n=5 Participants
26 Participants
n=7 Participants
60 Participants
n=5 Participants
oxidative stress markers
Native Thiol Mean(Standart Deviation) Unit of measure: mmol/L
13.96 mmol/L
STANDARD_DEVIATION 38.93 • n=5 Participants
2.31 mmol/L
STANDARD_DEVIATION 2.48 • n=7 Participants
8.13 mmol/L
STANDARD_DEVIATION 20.70 • n=5 Participants
oxidative stress markers
Total Thiol Mean(Standart Deviation) Unit of measure: mmol/L
34.75 mmol/L
STANDARD_DEVIATION 48.44 • n=5 Participants
19.76 mmol/L
STANDARD_DEVIATION 2.93 • n=7 Participants
27.25 mmol/L
STANDARD_DEVIATION 25.68 • n=5 Participants
oxidative stress markers
Disülfide Mean(Standart Deviation) Unit of measure: mmol/L
10.76 mmol/L
STANDARD_DEVIATION 6.5 • n=5 Participants
8.75 mmol/L
STANDARD_DEVIATION 1.84 • n=7 Participants
9.75 mmol/L
STANDARD_DEVIATION 4.17 • n=5 Participants
BMI
27.94 kg/m²
STANDARD_DEVIATION 5.28 • n=5 Participants
27.76 kg/m²
STANDARD_DEVIATION 5.93 • n=7 Participants
27.85 kg/m²
STANDARD_DEVIATION 5.605 • n=5 Participants
Mean RNFL, Temporal RNFL, CMT
Mean RNFL Mean (standard Deviation) Unit of measure:µm
101.91 µm
STANDARD_DEVIATION 10.34 • n=5 Participants
100.23 µm
STANDARD_DEVIATION 10.87 • n=7 Participants
101.07 µm
STANDARD_DEVIATION 10.60 • n=5 Participants
Mean RNFL, Temporal RNFL, CMT
RNFL Temporal Mean (standard Deviation) Unit of measure:µm
80.53 µm
STANDARD_DEVIATION 15.08 • n=5 Participants
70.81 µm
STANDARD_DEVIATION 16.43 • n=7 Participants
75.67 µm
STANDARD_DEVIATION 15.75 • n=5 Participants
Mean RNFL, Temporal RNFL, CMT
CMT Mean (standard Deviation) Unit of measure:µm
246.59 µm
STANDARD_DEVIATION 19.35 • n=5 Participants
252.08 µm
STANDARD_DEVIATION 18.36 • n=7 Participants
249.33 µm
STANDARD_DEVIATION 18.85 • n=5 Participants

PRIMARY outcome

Timeframe: 26 weeks of pregnant

Population: 34 control pregnant women and 26 pregnant women with impaired glucose tolerance were compared with fasting blood glucose and blood glucose at the 1st hour after 50 g sugar loading.

All patients underwent a 50-g GTT at any time of the day. Women with ≥ 140 mg/dL on the 50-g GTT in the first hour but with a normal 100-g oral GTT level were included in the hyperglycemia group. Women with a 50-g GTT level \< 140 mg/dL were categorized as normal and included in the control group

Outcome measures

Outcome measures
Measure
Control Group
n=34 Participants
Non diabetic women tear test and eye measurement: tear test and eye measurement
Case Group
n=26 Participants
Women with impairment glucose status tear test and eye measurement: tear test and eye measurement
Glucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
50 gr (1hour) Mean(Standart Deviation) Unit of measure: mg/dl
111.67 mg/dl
Standard Error 25.54
154 mg/dl
Standard Error 24.29
Glucose Levels of the Groups in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Fasting food sugar Mean(Standart Deviation) Unit of measure: mg/dl
83.06 mg/dl
Standard Error 11.33
88.15 mg/dl
Standard Error 14.33

SECONDARY outcome

Timeframe: 26 weeks pregnant women

Population: Retinal nerve fibre thickness and macular thickness were measured in 26 pregnant women with blood glucose disorders and/or gestational DM and 24 pregnant women in the control group.

Retinal nerve fiber thickness and macular (µm) are measured by OCT in pregnant women with impaired blood sugar and/or gestational DM RNFL (mean, superior, inferior, nasal, temporal), mean central macular thickness, macula 3mm (mean, superior, inferior, nasal, temporal) and macula 6mm (mean, superior, inferior, nasal, temporal) were measured

Outcome measures

Outcome measures
Measure
Control Group
n=34 Participants
Non diabetic women tear test and eye measurement: tear test and eye measurement
Case Group
n=26 Participants
Women with impairment glucose status tear test and eye measurement: tear test and eye measurement
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Mean RNFL Mean(Standart Deviation) Unit of measure:µm
101.91 µm
Standard Error 10.34
100.23 µm
Standard Error 10.87
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Superior RNFL Mean(Standart Deviation) Unit of measure:µm
123.82 µm
Standard Error 16.05
124.85 µm
Standard Error 15.78
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Inferior RNFL Mean(Standart Deviation) Unit of measure:µm
132.59 µm
Standard Error 15.92
128.23 µm
Standard Error 20.6
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Nasal RNFL Mean(Standart Deviation) Unit of measure:µm
72.12 µm
Standard Error 10.65
72.27 µm
Standard Error 11.81
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Temporal RNFL Mean(Standart Deviation) Unit of measure:µm
80.53 µm
Standard Error 15.08
70.81 µm
Standard Error 16.43
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula CMT Mean(Standart Deviation) Unit of measure:µm
246.59 µm
Standard Error 19.35
252.08 µm
Standard Error 18.36
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula 3mm Superior Mean(Standart Deviation) Unit of measure:µm
330.5 µm
Standard Error 14.79
333.5 µm
Standard Error 14.94
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula 3mm Inferior Mean(Standart Deviation) Unit of measure:µm
326.91 µm
Standard Error 15.33
330.92 µm
Standard Error 15.33
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula 3mm Nasal Mean(Standart Deviation) Unit of measure:µm
313.97 µm
Standard Error 11.98
316.88 µm
Standard Error 17.15
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula 3mm Temporal Mean(Standart Deviation) Unit of measure:µm
330.88 µm
Standard Error 13.51
330.65 µm
Standard Error 12.48
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula 6mm Superior Mean(Standart Deviation) Unit of measure:µm
299.21 µm
Standard Error 12.36
298.19 µm
Standard Error 12.72
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula 6mm Inferior Mean(Standart Deviation) Unit of measure:µm
292.32 µm
Standard Error 22.82
285.00 µm
Standard Error 10.10
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula 6mm Nasal Mean(Standart Deviation) Unit of measure:µm
280.44 µm
Standard Error 11.52
283.81 µm
Standard Error 10.26
Retinal Nerve Fiber Thickness and Macular Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Macula 6mm Temporal Mean(Standart Deviation) Unit of measure:µm
311.00 µm
Standard Error 10.88
307.92 µm
Standard Error 12.84

SECONDARY outcome

Timeframe: 26 weeks of pregnant

Population: Natural thiol values, total thiol and disulphide values in tears of 26 pregnant women with blood glucose disorders and/or gestational DM and 34 control subjects

Native thiol values, total thiol and disulfide values in tears in the pregnant group with blood sugar disorders and/or gestational DM, and control group

Outcome measures

Outcome measures
Measure
Control Group
n=34 Participants
Non diabetic women tear test and eye measurement: tear test and eye measurement
Case Group
n=26 Participants
Women with impairment glucose status tear test and eye measurement: tear test and eye measurement
Oxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Disülfide Mean(Standart Deviation) Unit of measure: mmol/L
10.76 mmol/L
Standard Deviation 6.5
8.75 mmol/L
Standard Deviation 1.84
Oxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Native Thiol Mean(Standart Deviation) Unit of measure: mmol/L
13.96 mmol/L
Standard Deviation 38.93
2.31 mmol/L
Standard Deviation 2.48
Oxidative Stress Level in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Total Thiol Mean(Standart Deviation) Unit of measure: mmol/L
34.75 mmol/L
Standard Deviation 48.44
19.76 mmol/L
Standard Deviation 2.93

SECONDARY outcome

Timeframe: 26 weeks of pregnant

Population: Retinal nerve fibre temporal quadrant thicknesses were measured in tears of 26 pregnant women with blood glucose disorders and/or gestational DM and 34 control subjects.

Retinal nerve fiber temporal quadrant thickness in the pregnant group with blood sugar disorders and/or gestational DM, and control group

Outcome measures

Outcome measures
Measure
Control Group
n=34 Participants
Non diabetic women tear test and eye measurement: tear test and eye measurement
Case Group
n=26 Participants
Women with impairment glucose status tear test and eye measurement: tear test and eye measurement
Retinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Temporal RNFL Mean(Standart Deviation) Unit of measure:µm
80.53 µm
Standard Deviation 15.08
70.81 µm
Standard Deviation 16.43
Retinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Nasal RNFL Mean(Standart Deviation) Unit of measure:µm
72.12 µm
Standard Deviation 10.65
72.27 µm
Standard Deviation 11.81
Retinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Superior RNFL Mean(Standart Deviation) Unit of measure:µm
123.82 µm
Standard Deviation 16.05
124.85 µm
Standard Deviation 15.78
Retinal Nerve Fiber Temporal Quadrant Thickness in Pregnant Women With Impaired Blood Sugar and/or Gestational DM
Inferior RNFL Mean(Standart Deviation) Unit of measure:µm
132.59 µm
Standard Deviation 15.92
128.23 µm
Standard Deviation 20.6

Adverse Events

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Case Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Suzan Doğruya

Usak University Medical Faculty

Phone: 05322270732

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place